Neuronuclear and Neuromelanin-Sensitive Imaging for Acquired Hepatocerebral Degeneration with Parkinsonism

Takashi Ogawa; Kotaro Ogaki; Yuko Mori; Hikaru Kamo; Akira Uchiyama; Koji Kamagata; Masanori Nagaoka; Nobutaka Hattori

doi:10.1002/mdc3.13166

Neuronuclear and Neuromelanin-Sensitive Imaging for Acquired Hepatocerebral Degeneration with Parkinsonism

Mov Disord Clin Pract. 2021 Mar 26;8(3):464-468. doi: 10.1002/mdc3.13166. eCollection 2021 Apr.

Authors

Takashi Ogawa¹, Kotaro Ogaki^{1

2}, Yuko Mori¹, Hikaru Kamo¹, Akira Uchiyama³, Koji Kamagata⁴, Masanori Nagaoka¹, Nobutaka Hattori¹

Affiliations

¹ Department of Neurology Juntendo University School of Medicine Tokyo Japan.
² Department of Neurology Juntendo University Urayasu Hospital Chiba Japan.
³ Department of Gastroenterology Juntendo University School of Medicine Tokyo Japan.
⁴ Department of Radiology Juntendo University School of Medicine Tokyo Japan.

No abstract available

Keywords: acquired hepatocerebral degeneration; dopamine transporter imaging; levodopa responsive parkinsonism; neuromelanin‐sensitive imaging; primary biliary cholangitis.

Publication types

Case Reports